Association of rs10954213 polymorphisms and haplotype diversity in interferon regulatory factor 5 with systemic lupus erythematosus: A meta-analysis

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 33, Issue 1, 2013, Pages 15-21

  Liu, Hui Feng ^a,b   An, Xiang Jie ^a   Yang, Yan ^c   Yang, Liu ^a   Li, Yan ^a   Huang, Chang Zheng ^a   Tao, Juan ^a   Tu, Ya Ting ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b Wuhan Institute of Dermatosis and Venereal Disease Preventing   (China)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

gene polymorphism; interferon regulatory factor 5 Hui feng; meta analysis; systemic lupus erythematosus

Indexed keywords

INTERFERON REGULATORY FACTOR; IRF5 PROTEIN, HUMAN;

ARTICLE; FEMALE; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENETICS; HAPLOTYPE; HUMAN; MALE; META ANALYSIS; PREVALENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS;

FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HAPLOTYPES; HUMANS; INTERFERON REGULATORY FACTORS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE;

EID: 84873628514     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-013-1064-4     Document Type: Article

References (32)

1. Blanco P, Palucka AK, Gill M, et al. Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science, 2001,294(5546):1540-1543
2. Ronnblom L, Alm GV. A pivotal role for the natural interferon alpha-producing cells (plasmacytoid dendritic cells) in the pathogenesis of lupus. J Exp Med, 2001,194(12):F59-63
3. Baechler EC, Batliwalla FM, Karypis G, et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci USA, 2003,100(5): 2610-2615
4. Harley JB, Kelly JA, Kaufman KM. Unraveling the genetics of systemic lupus erythematosus. Springer Semin Immunopathol, 2006,28(2):119-130
5. Obermoser G, Pascual V. The interferon-alpha signature of systemic lupus erythematosus. Lupus, 2010,19(9): 1012-1019
6. Crow MK. Interferon pathway activation in systemic lupus erythematosus. Curr Rheumatol Rep, 2005,7(6): 463-468
7. Petri M, Singh S, Tesfasyone H, et al. Longitudinal expression of type I interferon responsive genes in systemic lupus erythematosus. Lupus, 2009,18(11): 980-989
8. Banchereau J, Pascual V. Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity, 2006,25(3):383-392
9. Kawasaki M, Fujishiro M, Yamaguchi A, et al. Possible role of the JAK/STAT pathways in the regulation of T cell-interferon related genes in systemic lupus erythematosus. Lupus, 2011,20(12):1231-1239
10. Graham RR, Kozyrev SV, Baechler EC, et al. A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nat Genet, 2006,38(5):550-555
11. Graham RR, Kyogoku C, Sigurdsson S, et al. Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus. Proc Natl Acad Sci USA, 2007,104(16):6758-6763
12. Ferreiro-Neira I, Calaza M, Alonso-Perez E, et al. Opposed independent effects and epistasis in the complex association of IRF5 to SLE. Genes Immun, 2007,8(5): 429-438
13. Kawasaki A, Kyogoku C, Ohashi J, et al. Association of IRF5 polymorphisms with systemic lupus erythematosus in a Japanese population: support for a crucial role of intron 1 polymorphisms. Arthritis Rheum, 2008,58(3): 826-834
14. Kelly JA, Kelley JM, Kaufman KM, et al. Interferon regulatory factor-5 is genetically associated with systemic lupus erythematosus in African Americans. Genes Immun, 2008,9(3):187-194
15. Taniguchi T, Ogasawara K, Takaoka A, et al. IRF family of transcription factors as regulators of host defense. Annu Rev Immunol, 2001,19:623-655
16. Vuong MT, Gunnarsson I, Lundberg S, et al. Genetic risk factors in lupus nephritis and IgA nephropathy-no support of an overlap. PLoS One, 2010,5(5):e10559
17. Song WQ, Li HH, Chen HB, et al. Relationship between polymorphism sites of IRF5, TLR-9 and SLE patients in Shandong Han population. Zhonghua Yi Xue Za Zhi (Chinese), 2009,89(43):3038-3042
18. Löfgren SE, Yin H, Delgado-Vega AM, et al. Promoter insertion/deletion in the IRF5 gene is highly associated with susceptibility to systemic lupus erythematosus in distinct populations, but exerts a modest effect on gene expression in peripheral blood mononuclear cells. J Rheumatol, 2010,37(3):574-578
19. Hellquist A, Jarvinen TM, Koskenmies S, et al. Evidence for genetic association and interaction between the TYK2 and IRF5 genes in systemic lupus erythematosus. J Rheumatol, 2009,36(8):1631-1638
20. Sigurdsson S, Goring HH, Kristjansdottir G, et al. Comprehensive evaluation of the genetic variants of interferon regulatory factor 5 (IRF5) reveals a novel 5 bp length polymorphism as strong risk factor for systemic lupus erythematosus. Hum Mol Genet, 2008,17(6): 872-881
21. Reddy MV, Velazquez-Cruz R, Baca V, et al. Genetic association of IRF5 with SLE in Mexicans: higher frequency of the risk haplotype and its homozygozity than Europeans. Hum Genet, 2007,121(6):721-727
22. Kozyrev SV, Lewen S, Reddy PM, et al. Structural insertion/deletion variation in IRF5 is associated with a risk haplotype and defines the precise IRF5 isoforms expressed in systemic lupus erythematosus. Arthritis Rheum, 2007,56(4):1234-1241
23. Siu HO, Yang W, Lau CS, et al. Association of a haplotype of IRF5 gene with systemic lupus erythematosus in Chinese. J Rheumatol, 2008,35(2): 360-362
24. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med, 2002,21(11):1539-1558
25. Zintzaras E, Chatzoulis DZ, Karabatsas CH, et al. The relationship between C677T methylenetetrahydrofolate reductase gene polymorphism and retinopathy in type 2 diabetes: a meta-analysis. J Hum Genet, 2005,50(6): 267-275
26. Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ, 1997,315(7109):629-634
27. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomised clinical trials: is blinding necessary? Control Clin Trials, 1996,17(1):1-12
28. Liu K, Liu J, Huang Y, et al. Alpha-adducin Gly460Trp polymorphism and hypertension risk: a meta-analysis of 22 studies including 14303 cases and 15961 controls. PLoS One, 2010,5(9):e13057
29. Hu W, Ren H. A meta-analysis of the association of IRF5 polymorphism with systemiclupus erythematosus. Int J Immunogenet, 2011,38(5): 411-417
30. Barnes BJ, Richards J, Mancl M, et al. Global and distinct targets of IRF-5 and IRF-7 during innate response to viral infection. J Biol Chem, 2004,279(43):45 194-45 207
31. Honda K, Yanai H, Takaoka A, et al. Regulation of the type I IFN induction: a current view. Int Immunol, 2005,17(11):1367-1378
32. Takaoka A, Yanai H, Kondo S, et al. Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature, 2005,434(7030):243-249